Related Experiment Videos
Relationships between proteasomes and viral gene products
A S Jarrousse1, K Gautier, S Apcher
1Laboratoire OVGV UA INRA 987, equipe Protéasome & Auto-Surveillance Cellulaire, Université Blaise Pascal Clermont-Fd, Aubière, France.
Molecular Biology Reports
|June 11, 1999
Summary
Proteasomes interact with viral gene products, affecting viral mRNA and antigen presentation. This review focuses on human immunodeficiency virus (HIV) interactions with 20S proteasomes.
Area of Science:
- Molecular Biology
- Virology
- Immunology
Background:
- Proteasomes are crucial cellular machines involved in protein degradation and antigen processing.
- Viruses have evolved mechanisms to interact with and manipulate host cell proteasome functions.
- The interplay between proteasomes and viral elements is complex and multifaceted.
Purpose of the Study:
- To review the intricate relationships between proteasomes and viral gene products.
- To highlight the role of proteasome activities in viral mRNA processing and antigen presentation.
- To focus on the specific interactions between 20S proteasomes and human immunodeficiency virus (HIV) gene products.
Main Methods:
- Literature review of studies on proteasome-virus interactions.
- Analysis of proteasome endonuclease and endopeptidase activities in relation to viral components.
- Examination of viral protein association with 20S and 26S proteasome complexes.
Main Results:
- Proteasomes associate with viral mRNAs, leading to cleavage via endonuclease activity.
- Proteasome endopeptidase activities are integral to the presentation of viral antigens.
- Viral proteins from various sources interact with 20S and 26S proteasomes, modulating their enzymatic functions.
Conclusions:
- Proteasome-viral gene product interactions significantly impact viral replication and host immune response.
- The human immunodeficiency virus (HIV) provides a detailed case study for understanding these complex interrelationships.
- Further research into these interactions can reveal novel therapeutic targets.